BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28198610)

  • 1. Disentangling Nanonets: Human α-Defensin 6 Targets Candida albicans Virulence.
    Cegelski L
    Biochemistry; 2017 Feb; 56(8):1027-1028. PubMed ID: 28198610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenic and protective Candida albicans constituents.
    Cassone A; De Bernardis F; Ausiello CM; Gomez MJ; Boccanera M; La Valle R; Torosantucci A
    Res Immunol; 1998; 149(4-5):289-99; discussion 504. PubMed ID: 9720947
    [No Abstract]   [Full Text] [Related]  

  • 3. Human α-Defensin 6: A Small Peptide That Self-Assembles and Protects the Host by Entangling Microbes.
    Chairatana P; Nolan EM
    Acc Chem Res; 2017 Apr; 50(4):960-967. PubMed ID: 28296382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human α-Defensin 6 Self-Assembly Prevents Adhesion and Suppresses Virulence Traits of Candida albicans.
    Chairatana P; Chiang IL; Nolan EM
    Biochemistry; 2017 Feb; 56(8):1033-1041. PubMed ID: 28026958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Looking into Candida albicans infection, host response, and antifungal strategies.
    Wang Y
    Virulence; 2015; 6(4):307-8. PubMed ID: 25590793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.
    Höfs S; Mogavero S; Hube B
    J Microbiol; 2016 Mar; 54(3):149-69. PubMed ID: 26920876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased resistance in BALB/c mice to reinfection with Candida albicans is due to immunoneutralization of a virulence-associated immunomodulatory protein.
    Tavares D; Ferreira P; Arala-Chaves M
    Microbiology (Reading); 2003 Feb; 149(Pt 2):333-339. PubMed ID: 12624195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigens and immune responses in Candida albicans infection.
    Ashman RB; Papadimitriou JM; Ott AK; Warmington JR
    Immunol Cell Biol; 1990 Feb; 68 ( Pt 1)():1-13. PubMed ID: 2180814
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunology. HD6 defensin nanonets.
    Ouellette AJ; Selsted ME
    Science; 2012 Jul; 337(6093):420-1. PubMed ID: 22837514
    [No Abstract]   [Full Text] [Related]  

  • 10. Candida albicans: pathogenesis, immunity and host defence.
    Ashman RB
    Res Immunol; 1998; 149(4-5):281-8; discussion 494-6. PubMed ID: 9720946
    [No Abstract]   [Full Text] [Related]  

  • 11. Candida albicans escapes from mouse neutrophils.
    Ermert D; Niemiec MJ; Röhm M; Glenthøj A; Borregaard N; Urban CF
    J Leukoc Biol; 2013 Aug; 94(2):223-36. PubMed ID: 23650619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-deficient Drosophila melanogaster: a model for the innate immune response to human fungal pathogens.
    Alarco AM; Marcil A; Chen J; Suter B; Thomas D; Whiteway M
    J Immunol; 2004 May; 172(9):5622-8. PubMed ID: 15100306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida albicans pathogenicity and epithelial immunity.
    Naglik JR; Richardson JP; Moyes DL
    PLoS Pathog; 2014 Aug; 10(8):e1004257. PubMed ID: 25121985
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of pathogenesis and host immune responses to Candida glabrata and Candida albicans in systemically infected immunocompetent mice.
    Brieland J; Essig D; Jackson C; Frank D; Loebenberg D; Menzel F; Arnold B; DiDomenico B; Hare R
    Infect Immun; 2001 Aug; 69(8):5046-55. PubMed ID: 11447185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of calcineurin in stress resistance, morphogenesis, and virulence of a Candida albicans wild-type strain.
    Bader T; Schröppel K; Bentink S; Agabian N; Köhler G; Morschhäuser J
    Infect Immun; 2006 Jul; 74(7):4366-9. PubMed ID: 16790813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adaptive immune responses to Candida albicans infection.
    Richardson JP; Moyes DL
    Virulence; 2015; 6(4):327-37. PubMed ID: 25607781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is a vaccine needed against Candida albicans?
    Mochon AB; Cutler JE
    Med Mycol; 2005 Mar; 43(2):97-115. PubMed ID: 15832554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Candida albicans filamentation for antifungal drug development.
    Vila T; Romo JA; Pierce CG; McHardy SF; Saville SP; Lopez-Ribot JL
    Virulence; 2017 Feb; 8(2):150-158. PubMed ID: 27268130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mnn10 Maintains Pathogenicity in Candida albicans by Extending α-1,6-Mannose Backbone to Evade Host Dectin-1 Mediated Antifungal Immunity.
    Zhang SQ; Zou Z; Shen H; Shen SS; Miao Q; Huang X; Liu W; Li LP; Chen SM; Yan L; Zhang JD; Zhao JJ; Xu GT; An MM; Jiang YY
    PLoS Pathog; 2016 May; 12(5):e1005617. PubMed ID: 27144456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting Candida albicans Infection from the Perspective of C. albicans Virulence and Omics Approaches on Host-Pathogen Interaction: A Review.
    Chin VK; Lee TY; Rusliza B; Chong PP
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.